Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Axon Enterprise Inc a un objectif de cours consensus de $681, basé sur les évaluations des 20 analystes. Le plus élevé est de $1000 attribué par B of A Securities le août 6, 2025, et le plus bas est de $309 attribué par Credit Suisse le mai 10, 2023. Les 3 dernières évaluations d'analystes ont été publiées par B of A Securities, Craig-Hallum et Raymond James le août 6, 2025, août 5, 2025 et août 5, 2025. Avec un objectif de cours moyen de $918.33 entre B of A Securities, Craig-Hallum et Raymond James, il y a une variation implicite de 22.72% upside pour Axon Enterprise Inc à partir de ces dernières évaluations d'analystes.
1calculé à partir des notes des analystes
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
08/06/2025 | 33.64% | B of A Securities | $895 → $1000 | Maintains | Buy | |||
08/05/2025 | 20.27% | Craig-Hallum | → $900 | Upgrade | Hold → Buy | |||
08/05/2025 | 14.26% | Raymond James | $645 → $855 | Maintains | Outperform | |||
08/05/2025 | 12.25% | UBS | $820 → $840 | Maintains | Neutral | |||
08/05/2025 | 16.26% | Needham | $820 → $870 | Maintains | Buy | |||
07/22/2025 | 10.25% | JMP Securities | $725 → $825 | Maintains | Market Outperform | |||
07/17/2025 | 13.59% | JP Morgan | $730 → $850 | Maintains | Overweight | |||
07/16/2025 | 9.58% | UBS | → $820 | Initiates | → Neutral | |||
07/08/2025 | — | Wolfe Research | — | Initiates | → Outperform | |||
06/04/2025 | 19.6% | B of A Securities | $750 → $895 | Maintains | Buy | |||
05/14/2025 | 10.92% | Goldman Sachs | $730 → $830 | Maintains | Buy | |||
05/09/2025 | -1.78% | Barclays | $726 → $735 | Maintains | Overweight | |||
05/08/2025 | 0.23% | Needham | $600 → $750 | Maintains | Buy | |||
04/23/2025 | -19.82% | Needham | $600 → $600 | Reiterates | Buy → Buy | |||
02/27/2025 | -2.98% | Barclays | $585 → $726 | Maintains | Overweight | |||
02/26/2025 | -3.11% | Citizens Capital Markets | $725 → $725 | Reiterates | Market Outperform → Market Outperform | |||
02/26/2025 | -19.82% | Needham | $600 → $600 | Reiterates | Buy → Buy | |||
02/20/2025 | -16.48% | Craig-Hallum | → $625 | Downgrade | Buy → Hold | |||
02/04/2025 | -3.11% | JMP Securities | $610 → $725 | Maintains | Market Outperform | |||
01/27/2025 | -6.45% | Goldman Sachs | $500 → $700 | Maintains | Buy | |||
01/08/2025 | -6.45% | TD Cowen | → $700 | Initiates | → Buy | |||
12/06/2024 | 6.91% | Baird | $600 → $800 | Maintains | Outperform | |||
12/03/2024 | -6.45% | Morgan Stanley | $500 → $700 | Upgrade | Equal-Weight → Overweight | |||
11/11/2024 | -21.82% | Barclays | $387 → $585 | Maintains | Overweight | |||
11/11/2024 | -26.5% | Northland Capital Markets | $365 → $550 | Maintains | Outperform | |||
11/08/2024 | -18.48% | JMP Securities | $500 → $610 | Maintains | Market Outperform | |||
11/08/2024 | -19.82% | Needham | $525 → $600 | Maintains | Buy | |||
11/08/2024 | -19.82% | Baird | $460 → $600 | Maintains | Outperform | |||
11/04/2024 | -38.53% | Baird | $440 → $460 | Maintains | Outperform | |||
10/31/2024 | -33.18% | JMP Securities | $430 → $500 | Maintains | Market Outperform | |||
10/23/2024 | -41.07% | Goldman Sachs | $385 → $441 | Maintains | Buy | |||
10/22/2024 | -29.84% | Needham | $400 → $525 | Maintains | Buy | |||
09/12/2024 | -42.54% | JMP Securities | $375 → $430 | Maintains | Market Outperform | |||
09/10/2024 | -46.55% | Baird | $360 → $400 | Maintains | Outperform | |||
09/09/2024 | -49.89% | JMP Securities | $375 → $375 | Reiterates | Market Outperform → Market Outperform | |||
08/08/2024 | -51.22% | Northland Capital Markets | $330 → $365 | Maintains | Outperform | |||
08/07/2024 | -49.89% | JMP Securities | $375 → $375 | Reiterates | Market Outperform → Market Outperform | |||
08/07/2024 | -48.28% | Barclays | $381 → $387 | Maintains | Overweight | |||
08/07/2024 | -49.75% | Craig-Hallum | $370 → $376 | Maintains | Buy | |||
08/07/2024 | -51.89% | Baird | $355 → $360 | Maintains | Outperform | |||
08/07/2024 | -46.55% | Needham | $400 → $400 | Reiterates | Buy → Buy | |||
07/17/2024 | -48.55% | Jefferies | → $385 | Initiates | → Buy | |||
07/17/2024 | -49.22% | B of A Securities | → $380 | Initiates | → Buy | |||
05/08/2024 | -49.08% | Barclays | $308 → $381 | Maintains | Overweight | |||
05/07/2024 | -49.89% | JMP Securities | $375 → $375 | Reiterates | Market Outperform → Market Outperform | |||
05/07/2024 | -46.55% | Needham | $400 → $400 | Reiterates | Buy → Buy | |||
05/07/2024 | -50.55% | Craig-Hallum | $325 → $370 | Maintains | Buy | |||
05/01/2024 | -49.89% | JMP Securities | $320 → $375 | Maintains | Market Outperform | |||
04/26/2024 | -58.57% | Morgan Stanley | $285 → $310 | Maintains | Equal-Weight | |||
04/24/2024 | -46.55% | Needham | $400 → $400 | Reiterates | Buy → Buy | |||
04/11/2024 | -51.22% | JP Morgan | $330 → $365 | Maintains | Overweight | |||
04/10/2024 | -46.55% | Needham | $315 → $400 | Maintains | Buy | |||
03/13/2024 | -49.22% | Argus Research | → $380 | Initiates | → Buy | |||
02/29/2024 | -58.84% | Barclays | $296 → $308 | Maintains | Overweight | |||
02/28/2024 | -61.91% | Morgan Stanley | $250 → $285 | Maintains | Equal-Weight | |||
02/28/2024 | -54.7% | Goldman Sachs | $297 → $339 | Maintains | Buy | |||
02/28/2024 | -55.9% | JP Morgan | $285 → $330 | Maintains | Overweight | |||
02/28/2024 | -57.9% | Needham | $240 → $315 | Maintains | Buy | |||
02/22/2024 | -59.91% | Baird | $260 → $300 | Maintains | Outperform | |||
02/06/2024 | -61.91% | JMP Securities | $250 → $285 | Maintains | Market Outperform | |||
02/02/2024 | -67.93% | Needham | $240 → $240 | Reiterates | Buy → Buy | |||
01/02/2024 | -60.44% | Barclays | $247 → $296 | Maintains | Overweight | |||
11/08/2023 | -68.86% | Raymond James | $223 → $233 | Maintains | Outperform | |||
09/29/2023 | -68.6% | JMP Securities | → $235 | Reiterates | Market Outperform → Market Outperform | |||
08/22/2023 | -69.26% | Morgan Stanley | → $230 | Initiates | → Equal-Weight | |||
08/11/2023 | -68.6% | Northland Capital Markets | $227 → $235 | Maintains | Outperform | |||
08/09/2023 | -68.06% | Barclays | $256 → $239 | Maintains | Overweight | |||
08/09/2023 | -67.93% | Needham | → $240 | Reiterates | Buy → Buy | |||
05/11/2023 | -67.93% | Baird | $237 → $240 | Maintains | Outperform | |||
05/11/2023 | -68.46% | JP Morgan | → $236 | Upgrade | Neutral → Overweight | |||
05/10/2023 | -68.6% | JMP Securities | → $235 | Reiterates | → Market Outperform | |||
05/10/2023 | -58.71% | Credit Suisse | $300 → $309 | Maintains | Outperform | |||
05/10/2023 | -67.93% | Needham | → $240 | Reiterates | → Buy | |||
05/10/2023 | -65.79% | Barclays | $222 → $256 | Maintains | Overweight | |||
04/14/2023 | -68.6% | JMP Securities | → $235 | Reiterates | → Market Outperform | |||
04/13/2023 | -67.93% | Needham | → $240 | Reiterates | → Buy | |||
04/11/2023 | -59.91% | Credit Suisse | $237 → $300 | Maintains | Outperform | |||
03/08/2023 | -64.85% | Goldman Sachs | → $263 | Initiates | → Buy | |||
03/02/2023 | -70.33% | Barclays | $177 → $222 | Maintains | Overweight | |||
03/02/2023 | -70.07% | JP Morgan | → $224 | Downgrade | Overweight → Neutral | |||
03/01/2023 | -68.33% | Baird | $200 → $237 | Maintains | Outperform | |||
03/01/2023 | -68.33% | Credit Suisse | $200 → $237 | Maintains | Outperform | |||
03/01/2023 | -67.93% | Needham | → $240 | Reiterates | → Buy | |||
02/17/2023 | -70.2% | Raymond James | → $223 | Downgrade | Strong Buy → Outperform | |||
02/01/2023 | -68.6% | JMP Securities | $195 → $235 | Maintains | Market Outperform | |||
01/10/2023 | -73.27% | Credit Suisse | $152 → $200 | Maintains | Outperform | |||
12/13/2022 | -79.29% | Morgan Stanley | $130 → $155 | Maintains | Equal-Weight | |||
11/09/2022 | -82.63% | Morgan Stanley | $120 → $130 | Maintains | Equal-Weight | |||
11/09/2022 | -79.69% | Credit Suisse | $142 → $152 | Maintains | Outperform | |||
11/09/2022 | -73.27% | Needham | $130 → $200 | Maintains | Buy | |||
09/15/2022 | -80.36% | Barclays | → $147 | Initiates | → Overweight |
Le dernier objectif de prix pour Axon Enterprise (NASDAQ:AXON) a été rapporté par B of A Securities le août 6, 2025. Le cabinet d'analystes a fixé un objectif de prix pour $1000.00 s'attendant à ce que AXON se rise dans les 12 prochains mois (un possible changement de 33.64% upside). 35 cabinets d'analystes ont rapporté des notes au cours de la dernière année.
La dernière note d'analyste pour Axon Enterprise (NASDAQ:AXON) a été fournie par B of A Securities, et Axon Enterprise maintenu leur note buy.
La dernière amélioration pour Axon Enterprise Inc a eu lieu le août 5, 2025 lorsque Craig-Hallum a augmenté leur objectif de prix à $900. Craig-Hallum avait précédemment a hold pour Axon Enterprise Inc.
La dernière réduction pour Axon Enterprise Inc a eu lieu le février 20, 2025 lorsque Craig-Hallum a changé leur objectif de prix de N/A à $625 pour Axon Enterprise Inc.
Les analystes arrivent à des évaluations d'actions après avoir effectué des recherches approfondies, ce qui inclut l'examen des états financiers publics, la discussion avec les dirigeants et les clients de Axon Enterprise, et l'écoute des conférences téléphoniques sur les résultats. La plupart des analystes font cela tous les trois mois, vous devriez donc obtenir 4 notes par entreprise par société chaque année. La dernière note pour Axon Enterprise a été déposée le août 6, 2025, donc vous devriez vous attendre à ce que la prochaine note soit disponible vers août 6, 2026.
Bien que les évaluations soient subjectives et changeront, la dernière note de Axon Enterprise (AXON) était un maintenu avec un objectif de prix de $895.00 à $1000.00. Le prix actuel de Axon Enterprise (AXON) est de $748.30, ce qui est out of la fourchette prédite par l'analyste.
Parcourir notes d'analystes et objectifs de cours sur toutes les actions.